A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.
about
External beam radiation dose escalation for high grade gliomaPharmacological therapy for depression in primary brain tumoursExternal beam radiation dose escalation for high grade gliomaThe evolving roles and controversies of radiotherapy in the treatment of glioblastomaRadiation and concomitant chemotherapy for patients with glioblastoma multiformeRadiation Therapy Intensification for Solid Tumors: A Systematic Review of Randomized TrialsMagnetic resonance perfusion imaging in neuro-oncology.Brain necrosis after permanent low-activity iodine-125 implants: case report and review of toxicity from focal radiation.Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approachesTemozolomide in the treatment of recurrent malignant glioma.Fractionated stereotactic radiotherapy boost and weekly paclitaxel in malignant gliomas clinical and pharmacokinetics results.Functional MRI for radiotherapy of gliomas.Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI.Chemotherapy for high-grade glioma.Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis.Cancer stem cells: the final frontier for glioma virotherapy.Hypofractionated intensity modulated radiotherapy with temozolomide in newly diagnosed glioblastoma multiformeIntegration of BOLD-fMRI and DTI into radiation treatment planning for high-grade gliomas located near the primary motor cortexes and corticospinal tractsINTRAGO: intraoperative radiotherapy in glioblastoma multiforme—a phase I/II dose escalation studyViews of bereaved relatives about quality of survival after radiotherapy for malignant cerebral gliomaDNA damage response and repair: insights into strategies for radiation sensitization of gliomasThe role of chemotherapy in anaplastic astrocytoma patients.Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme.Brachytherapy for brain tumors.3-D conformal radiotherapy with concomitant and adjuvant temozolomide for patients with glioblastoma multiforme and evaluation of prognostic factors.Role of radiotherapy in the treatment of gliomas.Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial.Hypofractionated Radiotherapy and Stereotactic Boost with Concurrent and Adjuvant Temozolamide for Glioblastoma in Good Performance Status Elderly Patients - Early Results of a Phase II Trial.Hypofractionated radiotherapy for glioblastoma: strategy for poor-risk patients or hope for the future?The role of radiotherapy and chemotherapy in the treatment of primary adult high grade gliomas: assessment of patients for these treatment approaches and the common immediate side effects.Trichosanthin suppresses the proliferation of glioma cells by inhibiting LGR5 expression and the Wnt/β-catenin signaling pathway.Malignant cerebral glioma--II: Perspectives of patients and relatives on the value of radiotherapy.Malignant cerebral glioma--I: Survival, disability, and morbidity after radiotherapy.Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings.Five-year follow-up results for patients diagnosed with anaplastic astrocytoma and effectiveness of concomitant therapy with temozolomide for recurrent anaplastic astrocytoma.The economics of temozolomide in brain cancer.Safety and efficacy of stereotactic radiosurgery and adjuvant bevacizumab in patients with recurrent malignant gliomas.ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.
P2860
Q24186922-3F0261EB-F962-4245-B219-8B352A40DD26Q24243551-A3657267-4B6E-4A2E-B053-7ECA7B4BE913Q26470382-313086A9-147A-41DE-908B-61DE922FC686Q26746622-798F85D2-447F-4A52-BA14-5127D15FD74AQ26827957-F3CE0143-58EB-4B62-80EA-B9A4D8DAC3D6Q30278410-9B1BB10D-8A9D-49F4-871D-BCAB21C57744Q30479156-3F8C77AF-1221-42E4-A558-EA0225F4D1FDQ30648926-6C507A4F-AF1A-4241-A28A-339EAFC88DD7Q30725125-A674591A-54EF-4401-967B-30A5191CA63AQ30890927-2EE47E30-FFB5-48B3-B0E5-7050D6608A01Q33286061-1A08D223-9D3F-448B-BBA5-023C436A5AC2Q33631456-CF5816A5-3265-4AF0-98AB-E7A43EC2819EQ33698886-C1F2053B-745C-46C3-A970-666AA2C39579Q33888366-50F39D93-791F-434B-A54F-013753BC78BDQ34169384-EB877269-E16D-479B-B6E1-BADC2621C879Q34471734-257E2949-13EE-431D-94F3-D495932ED1DCQ34516701-DCA520D0-5186-448B-9EC2-1250DF20D222Q34986417-DF93AD1C-1935-40BA-88B8-E988F529ED03Q35170123-20C0E20D-0AC5-4056-8E5C-9E805D81DC63Q35189570-88CF6B3E-28D5-4903-B3EE-5A67C9E18618Q35487337-61E4615E-9292-4AB6-8B2D-9212B1D6B343Q35608458-094D60AC-1D75-41DD-89D2-07E5F46043D6Q36041149-9BAD8470-8137-4A9E-BDF7-5DF30F22DBB7Q36081097-40B62987-4FFB-4CE7-843F-572D7D6E7505Q36100686-38FD9C10-DEB3-4A7C-AEA0-2D95D3195106Q36149662-70283796-34DF-4153-A8FF-3B89CC152B10Q36177805-59DB3EF5-40D5-4732-99E0-AEB68A44B88FQ36307807-516F3578-B9ED-4C51-B380-BA79EC73FDCDQ36318297-D62A39A1-BE56-4B1D-82E6-806CBD7762D8Q36320980-BCFBCEDB-3BCC-4628-AECE-DA10F237DD3AQ36365570-523922D7-6AD8-42D4-B263-D02BB158868CQ36487745-7EB14568-14AC-48EA-8625-4AEE65CFDDD9Q36490298-0A38DE52-F47F-4FB4-A465-79DB70C1C246Q36601731-666992CE-C273-4958-BDE2-94CF94C54EBCQ36601793-B0682DB6-E889-42DC-8FC7-FAD2E1B9F97EQ36649062-771654A2-A4BB-416C-8AD3-85854A131EE3Q36732622-562B368F-A1F3-430A-9230-A940956D3ADFQ36909282-4AE90D7A-27C5-4704-9B25-715E0B09065EQ36949475-35063E80-B5C6-4DDA-B1B0-A10A08B03114Q37021547-6363411E-101B-4C50-AD12-C1D9AB936AA8
P2860
A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. The Medical Research Council Brain Tumour Working Party.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
A Medical Research Council tri ...... il Brain Tumour Working Party.
@ast
A Medical Research Council tri ...... il Brain Tumour Working Party.
@en
type
label
A Medical Research Council tri ...... il Brain Tumour Working Party.
@ast
A Medical Research Council tri ...... il Brain Tumour Working Party.
@en
prefLabel
A Medical Research Council tri ...... il Brain Tumour Working Party.
@ast
A Medical Research Council tri ...... il Brain Tumour Working Party.
@en
P2860
P356
P1476
A Medical Research Council tri ...... il Brain Tumour Working Party.
@en
P2093
Bleehen NM
Stenning SP
P2860
P2888
P304
P356
10.1038/BJC.1991.396
P407
P577
1991-10-01T00:00:00Z